WellCare of Nebraska, a subsidiary of WellCare Health Plans, Inc. (NYSE: WCG), announced today that its medical director, Dr. Stephen Lazoritz, has received a governor appointment to the newly established Palliative Care and Quality of Life Advisory Council. [Read more…]

Research and knowledge on the effects of nut consumption on human health has increased in recent years, suggesting that nut consumption may play a key role in the prevention of chronic diseases, such as diabetes and cardiovascular disease (CVD), among others. [Read more…]

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Children’s Hospital & Medical Center of Omaha, one of U.S. News and World Report’s Best Children’s Hospitals for Cardiology and Heart Surgery, have signed a 10-year, strategic partnership to help drive innovation in pediatric care. Working together, Philips and Children’s will look to identify opportunities to enhance the quality and cost effectiveness of patient services, including focusing on connected solutions in diagnostic imaging, patient monitoring, respiratory solutions and clinical informatics. [Read more…]

Regentis Biomaterials announced today the start of its Phase III pivotal clinical trial of GelrinC for the treatment of focal knee cartilage defects with successful surgery on three patients in the U.S. and Denmark. These procedures are part of a Food and Drug Adminstration (FDA) approved Investigational Device Exemption (IDE) clinical study to compare GelrinC to microfracture, the current standard of care treatment. The clinical study will be used to support a Pre-market Approval Application (PMA) which will allow Regentis to market GelrinC in the U.S. [Read more…]

Upsher-Smith Laboratories, LLC. (Upsher-Smith) today announced the launch of KLOR-CON® Powder (Potassium Chloride) for oral solution, 20 mEq. The Company received approval of an abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) for this product, which will be marketed and distributed by Upsher-Smith. Sandoz, Inc. will continue as the licensed marketer and distributor in the U.S. for the balance of the KLOR-CON® line of potassium products. [Read more…]

WellCare of Nebraska, a subsidiary of WellCare Health Plans, Inc. (NYSE: WCG), has announced that its medical director, Dr. Stephen Lazoritz, has received a governor appointment to the newly established Palliative Care and Quality of Life Advisory Council. [Read more…]

Fullerton Healthcare Corporation Limited (“Fullerton Health” or the “Group”), a leading provider of corporate healthcare solutions across Asia Pacific, today announced a significant investment from Ping An Capital Co., Ltd. (“Ping An Capital”), the core equity investment platform of Ping An Insurance (Group) Company of China, Ltd (“Ping An of China”). [Read more…]

Amendola Communications has added population health technology pioneer HealthBI to its customer family. Amendola will be a key player in HealthBI’s plans for rapid growth in 2018, promoting solutions that are already the most widely deployed of their kind while expanding awareness of the company as a visionary thought leader in value-based and integrated care. [Read more…]

WellCare Health Plans, Inc. (NYSE: WCG) and the New York City Hispanic Chamber of Commerce (NYCHCC) announced today that WellCare of New York was awarded the inaugural Anthony Chiarelli Employment Engagement Award in honor of its “successful practices [that] have provided compelling results on the value of diversity in corporate America.” [Read more…]

Effective today, regulation reforms from the Centers for Medicare & Medicaid Services (CMS) mandate a new process for surveying the policies and procedures of nursing facilities across the U.S. [Read more…]